BioLASCO Taiwan Market Cap

BioLASCO Taiwan has a market cap or net worth of 870.81 million as of July 2, 2025. Its market cap has decreased by -2.44% in one year.

Market Cap

870.81M

Enterprise Value

826.63M

Revenue

304.65M

Ranking

n/a

PE Ratio

19.43

Stock Price

34.00

Market Cap Chart

Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 870.81M, a decrease of -44.92%. That is a compound annual growth rate of -7.65%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2025	870.81M	2.72%
Dec 31, 2024	847.76M	-0.30%
Dec 29, 2023	850.32M	11.22%
Dec 30, 2022	764.52M	-1.97%
Dec 30, 2021	779.89M	-13.74%
Dec 31, 2020	904.10M	-7.47%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	211.71B
PharmaEssentia	182.96B
Bora Pharmaceuticals Co., LTD.	84.72B
Lotus Pharmaceutical	58.11B
Polaris Group	30.66B
Oneness Biotech	29.60B
Center Laboratories	26.99B
TaiMed Biologics	24.85B

Market Cap Rankings